The Orchestration of High-Risk HPV-Induced Cervical Cancer: A Comprehensive Review

Cervical cancer, a malignancy affecting the cervix, is a significant global health concern and remains the primary cause of mortality among women. Extensive research has established a strong association between cervical cancer and human papillomavirus (HPV) infection, with the latter being identified as the predominant etiological factor responsible for the development of cervical cancer. Numerous infections have no symptoms and spontaneously disappear due to the host’s immune response. HPV infection increases the risk of contracting the virus through early sexual activity and having multiple partners. The degree of dysplasia determines the degree to which cervical intraepithelial neoplastic lesions (CINs) are histologically assessed. HPV infections can be asymptomatic and resolve on their own, but in some cases, particularly with high-risk strains of HPV, they can lead to aggressive malignancies. Persistent infection is a statistically significant illness because of the virus’s frequency, even if cancer development from this infection is uncommon. The current cytology diagnostic methods cannot accurately assess the size or severity of lesions. Women infected with carcinogenic HPV have a greater chance of disease development compared to those with noncarcinogenic infections or no HPV infection. The prevalence of the most prevalent strains in women with and without cervical cancer is variable. This study aims to provide a comprehensive understanding of the influence exerted by oncoplayers on the complex network of cell cycle regulators. Analysis of this correlation may provide valuable insights into the mechanisms that control cell cycle regulation when oncogenes, namely E6 and E7, are present.